The global alopecia market is expected to reach USD 16.02 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030. The approval of JAK inhibitors and tyrosine kinase inhibitors along with the rising target disease prevalence is expected to drive market growth. ![Global Alopecia Market]( "Global Alopecia Market")
The prevalence of alopecia areata (AA) and alopecia totalis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.
The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly’s Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer’s Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.
Another key factor driving the industry’s growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.
The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.
The prevalence of alopecia areata (AA) and alopecia totalis is increasing globally. It is one of the most commonly encountered problems in clinics in the U.S. As per a research article published in March 2023, in the U.S. and UK, AA accounted for 0.6% to 2% of the new cases encountered in dermatology clinics. In hospital-based studies performed worldwide the incidence of AA is estimated to range between 0.57% to 3.8%.
The approval of new targeted pharmaceutical treatments is a key factor driving the alopecia market growth. For instance, in June 2022, the U.S. FDA approved Lilly’s Olumiant oral tablets for the treatment of severe alopecia in adult patients and is the first systemic treatment approved. Another key drug that is anticipated to be approved in 2023 is Pfizer’s Ritlecitinib. It is a dual inhibitor of Janus kinase 3 (JAK3) and tyrosine kinases.
Another key factor driving the industry’s growth is the increasing awareness regarding alopecia and thereby increasing treatment rates worldwide. The increase in the level of consciousness regarding physical appearance is one of the major reasons for the rising number of people seeking treatment. Additionally, rising investments in R&D and funding are also fueling market growth.
The limited availability of targeted drugs that treat the underlying condition is one key challenge for the market. While new products with targeted mechanisms of action are being approved the high cost of these drugs in comparison to the already approved products is one of the major hindrances in their widespread adoption.
Alopecia Market Report Highlights
- The alopecia universalis segment is expected to witness the fastest growth from 2024 to 2030, owing to the impending approval of pipeline products, such as Pfizer’s Ritlecitinib which is in the pre-registration phase, and Bioniz Therapeutics’s BNZ-1 which is in phase 2 clinical trials
- North America dominated the market in 2023, mainly due to the high consumer awareness, technological advancements, high target disease population, and high healthcare spending
- Asia-Pacific is expected to grow at the highest CAGR during the forecast period. This can be majorly attributed to the rising target disease population and rising treatment rate for the disease.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease Type
1.2.2. Treatment
1.2.3. Gender
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for Primary Interviews in Europe
1.4.5.3. Data for Primary Interviews in Asia-Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Disease Type
1.2.2. Treatment
1.2.3. Gender
1.2.4. Sales Channel
1.2.5. End Use
1.2.6. Regional Scope
1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.5.1. Data for Primary Interviews in North America
1.4.5.2. Data for Primary Interviews in Europe
1.4.5.3. Data for Primary Interviews in Asia-Pacific
1.4.5.4. Data for Primary Interviews in Latin America
1.4.5.5. Data for Primary Interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Disease Type
2.2.2. Treatment
2.2.3. Gender
2.2.4. Sales Channel
2.2.5. End Use
2.2.6. Regional outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.2.1. Disease Type
2.2.2. Treatment
2.2.3. Gender
2.2.4. Sales Channel
2.2.5. End Use
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. Alopecia Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing global prevalence of alopecia
3.2.1.2. Increasing global healthcare expenditure
3.2.1.3. Increasing prevalence of chronic diseases
3.2.1.3.1. PCOS
3.2.1.3.2. Cancer
3.2.1.3.3. Rheumatoid Arthritis
3.2.1.4. Technological advancements in alopecia treatment
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement policies for alopecia treatment
3.2.2.2. Increasing adoption of substitutes
3.3. Alopecia Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Pricing Analysis
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing global prevalence of alopecia
3.2.1.2. Increasing global healthcare expenditure
3.2.1.3. Increasing prevalence of chronic diseases
3.2.1.3.1. PCOS
3.2.1.3.2. Cancer
3.2.1.3.3. Rheumatoid Arthritis
3.2.1.4. Technological advancements in alopecia treatment
3.2.2. Market restraint analysis
3.2.2.1. Lack of reimbursement policies for alopecia treatment
3.2.2.2. Increasing adoption of substitutes
3.3. Alopecia Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.4. Pricing Analysis
Chapter 4. Alopecia Market: Disease Type Estimates & Trend Analysis
4.1. Disease Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Alopecia Market by Disease Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Alopecia Areata
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Male
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Female
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Cicatricial Alopecia
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Male
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Female
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Traction Alopecia
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Male
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Female
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Alopecia Totalis
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Male
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Female
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alopecia Universalis
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Male
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Female
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Androgenetic Alopecia
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.2. Male
4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.3. Female
4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.2. Male
4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.3. Female
4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.2. Segment Dashboard
4.3. Global Alopecia Market by Disease Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Alopecia Areata
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Male
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Female
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Cicatricial Alopecia
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.2. Male
4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2.3. Female
4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Traction Alopecia
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.2. Male
4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3.3. Female
4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Alopecia Totalis
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.2. Male
4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4.3. Female
4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Alopecia Universalis
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Male
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Female
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6. Androgenetic Alopecia
4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.2. Male
4.4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.6.3. Female
4.4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7. Others
4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.2. Male
4.4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.7.3. Female
4.4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Alopecia Market: Treatment Estimates & Trend Analysis
5.1. Treatment Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Alopecia Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Pharmaceuticals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Topical
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2. OTC
5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.2. Minoxidil
5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.3. Others
5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3. Prescription
5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.2. Betamethasone Dipropionate
5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.3. Fluocinolone Acetonide
5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.4. Finasteride
5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.5. Minoxidil
5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Oral
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.2. OTC
5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3. Prescription
5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.2. Minoxidil
5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.3. Finasteride
5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.4. Corticosteroids
5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.5. Others (JAK inhibitors and others)
5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. PRP
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Devices
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Laser Cap
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.2. Laser Comb
5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.4. Laser Helmet
5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)
5.2. Segment Dashboard
5.3. Global Alopecia Market by Treatment Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Pharmaceuticals
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2. Topical
5.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2. OTC
5.4.1.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.2. Minoxidil
5.4.1.2.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.2.3. Others
5.4.1.2.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3. Prescription
5.4.1.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.2. Betamethasone Dipropionate
5.4.1.2.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.3. Fluocinolone Acetonide
5.4.1.2.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.4. Finasteride
5.4.1.2.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.2.3.5. Minoxidil
5.4.1.2.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3. Oral
5.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.2. OTC
5.4.1.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3. Prescription
5.4.1.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.2. Minoxidil
5.4.1.3.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.3. Finasteride
5.4.1.3.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.4. Corticosteroids
5.4.1.3.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.3.3.5. Others (JAK inhibitors and others)
5.4.1.3.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.1.4. PRP
5.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Devices
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2. Laser Cap
5.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.2. Laser Comb
5.4.2.2.3. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2.2.4. Laser Helmet
5.4.2.2.5. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Alopecia Market: Gender Estimates & Trend Analysis
6.1. Gender Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Alopecia Market by Gender Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Prescriptions
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Female
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.2. Segment Dashboard
6.3. Global Alopecia Market by Gender Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Prescriptions
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
6.4.2. Female
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Alopecia Market: Sales Channel Estimates & Trend Analysis
7.1. Sales Channel Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Alopecia Market by Gender Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Prescription
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. OTC
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.2. Segment Dashboard
7.3. Global Alopecia Market by Gender Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Prescription
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
7.4.2. OTC
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Alopecia Market: End Use Estimates & Trend Analysis
8.1. End Use Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Alopecia Market by End Use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Homecare Settings
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.4.2. Dermatology Clinics
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.2. Segment Dashboard
8.3. Global Alopecia Market by End Use Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.4.1. Homecare Settings
8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
8.4.2. Dermatology Clinics
8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Alopecia Market: Regional Estimates & Trend Analysis
9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia-Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework/ reimbursement structure
9.8.3.3. Competitive scenario
9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
9.5. North America
9.5.1. U.S.
9.5.1.1. Key country dynamics
9.5.1.2. Regulatory framework/ reimbursement structure
9.5.1.3. Competitive scenario
9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
9.5.2. Canada
9.5.2.1. Key country dynamics
9.5.2.2. Regulatory framework/ reimbursement structure
9.5.2.3. Competitive scenario
9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
9.6.1. UK
9.6.1.1. Key country dynamics
9.6.1.2. Regulatory framework/ reimbursement structure
9.6.1.3. Competitive scenario
9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
9.6.2. Germany
9.6.2.1. Key country dynamics
9.6.2.2. Regulatory framework/ reimbursement structure
9.6.2.3. Competitive scenario
9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
9.6.3. France
9.6.3.1. Key country dynamics
9.6.3.2. Regulatory framework/ reimbursement structure
9.6.3.3. Competitive scenario
9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
9.6.4. Italy
9.6.4.1. Key country dynamics
9.6.4.2. Regulatory framework/ reimbursement structure
9.6.4.3. Competitive scenario
9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
9.6.5. Spain
9.6.5.1. Key country dynamics
9.6.5.2. Regulatory framework/ reimbursement structure
9.6.5.3. Competitive scenario
9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
9.6.6. Norway
9.6.6.1. Key country dynamics
9.6.6.2. Regulatory framework/ reimbursement structure
9.6.6.3. Competitive scenario
9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
9.6.7. Sweden
9.6.7.1. Key country dynamics
9.6.7.2. Regulatory framework/ reimbursement structure
9.6.7.3. Competitive scenario
9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
9.6.8. Denmark
9.6.8.1. Key country dynamics
9.6.8.2. Regulatory framework/ reimbursement structure
9.6.8.3. Competitive scenario
9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia-Pacific
9.7.1. Japan
9.7.1.1. Key country dynamics
9.7.1.2. Regulatory framework/ reimbursement structure
9.7.1.3. Competitive scenario
9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
9.7.2. China
9.7.2.1. Key country dynamics
9.7.2.2. Regulatory framework/ reimbursement structure
9.7.2.3. Competitive scenario
9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
9.7.3. India
9.7.3.1. Key country dynamics
9.7.3.2. Regulatory framework/ reimbursement structure
9.7.3.3. Competitive scenario
9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
9.7.4. Australia
9.7.4.1. Key country dynamics
9.7.4.2. Regulatory framework/ reimbursement structure
9.7.4.3. Competitive scenario
9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
9.7.5. South Korea
9.7.5.1. Key country dynamics
9.7.5.2. Regulatory framework/ reimbursement structure
9.7.5.3. Competitive scenario
9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
9.7.6. Thailand
9.7.6.1. Key country dynamics
9.7.6.2. Regulatory framework/ reimbursement structure
9.7.6.3. Competitive scenario
9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
9.8.1. Brazil
9.8.1.1. Key country dynamics
9.8.1.2. Regulatory framework/ reimbursement structure
9.8.1.3. Competitive scenario
9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
9.8.2. Mexico
9.8.2.1. Key country dynamics
9.8.2.2. Regulatory framework/ reimbursement structure
9.8.2.3. Competitive scenario
9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
9.8.3. Argentina
9.8.3.1. Key country dynamics
9.8.3.2. Regulatory framework/ reimbursement structure
9.8.3.3. Competitive scenario
9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
9.9.1. South Africa
9.9.1.1. Key country dynamics
9.9.1.2. Regulatory framework/ reimbursement structure
9.9.1.3. Competitive scenario
9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
9.9.2. Saudi Arabia
9.9.2.1. Key country dynamics
9.9.2.2. Regulatory framework/ reimbursement structure
9.9.2.3. Competitive scenario
9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
9.9.3. UAE
9.9.3.1. Key country dynamics
9.9.3.2. Regulatory framework/ reimbursement structure
9.9.3.3. Competitive scenario
9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
9.9.4. Kuwait
9.9.4.1. Key country dynamics
9.9.4.2. Regulatory framework/ reimbursement structure
9.9.4.3. Competitive scenario
9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, by Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Janssen Global Services Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Cipla Limited
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Merck & Co., Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. GlaxoSmithKline plc
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Sun Pharmaceuticals Industries Ltd
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Dr. Reddy’s Laboratories Ltd
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Aurobindo Pharma
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Viatris Inc.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Pfizer, Inc.
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Lilly
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Lexington Intl., LLC (Devices)
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Freedom Laser Therapy (iRestore ID-520 helmet)
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Curallux, LLC.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Apira Science Inc. (iGROW Laser)
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Revian Inc.
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
10.3.19. Theradome
10.3.19.1. Company overview
10.3.19.2. Financial performance
10.3.19.3. Product benchmarking
10.3.19.4. Strategic initiatives
10.3.20. Lutronic
10.3.20.1. Company overview
10.3.20.2. Financial performance
10.3.20.3. Product benchmarking
10.3.20.4. Strategic initiatives
10.2. Company/Competition Categorization
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Key company market share analysis, 2023
10.3.4. Janssen Global Services Inc.
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Cipla Limited
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Merck & Co., Inc.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. GlaxoSmithKline plc
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Sun Pharmaceuticals Industries Ltd
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Dr. Reddy’s Laboratories Ltd
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Aurobindo Pharma
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Viatris Inc.
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Pfizer, Inc.
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Lilly
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Lexington Intl., LLC (Devices)
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Freedom Laser Therapy (iRestore ID-520 helmet)
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Curallux, LLC.
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Apira Science Inc. (iGROW Laser)
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Revian Inc.
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product benchmarking
10.3.18.4. Strategic initiatives
10.3.19. Theradome
10.3.19.1. Company overview
10.3.19.2. Financial performance
10.3.19.3. Product benchmarking
10.3.19.4. Strategic initiatives
10.3.20. Lutronic
10.3.20.1. Company overview
10.3.20.2. Financial performance
10.3.20.3. Product benchmarking
10.3.20.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America alopecia market, by region, 2018-2030 (USD Million)
Table 3 North America alopecia market, by disease type, 2018-2030 (USD Million)
Table 4 North America alopecia market, by treatment, 2018-2030 (USD Million)
Table 5 North America alopecia market, by gender, 2018-2030 (USD Million)
Table 6 North America alopecia market, by sales channel, 2018-2030 (USD Million)
Table 7 North America alopecia market, by end user, 2018-2030 (USD Million)
Table 8 U.S. alopecia market, by disease type, 2018-2030 (USD Million)
Table 9 U.S. alopecia market, by treatment, 2018-2030 (USD Million)
Table 10 U.S. alopecia market, by gender, 2018-2030 (USD Million)
Table 11 U.S. alopecia market, by sales channel, 2018-2030 (USD Million)
Table 12 U.S. alopecia market, by end user, 2018-2030 (USD Million)
Table 13 Canada alopecia market, by disease type, 2018-2030 (USD Million)
Table 14 Canada alopecia market, by treatment, 2018-2030 (USD Million)
Table 15 Canada alopecia market, by gender, 2018-2030 (USD Million)
Table 16 Canada alopecia market, by sales channel, 2018-2030 (USD Million)
Table 17 Canada alopecia market, by end user, 2018-2030 (USD Million)
Table 18 Europe alopecia market, by region, 2018-2030 (USD Million)
Table 19 Europe alopecia market, by disease type, 2018-2030 (USD Million)
Table 20 Europe alopecia market, by treatment, 2018-2030 (USD Million)
Table 21 Europe alopecia market, by gender, 2018-2030 (USD Million)
Table 22 Europe alopecia market, by sales channel, 2018-2030 (USD Million)
Table 23 Europe alopecia market, by end user, 2018-2030 (USD Million)
Table 24 Germany alopecia market, by disease type, 2018-2030 (USD Million)
Table 25 Germany alopecia market, by treatment, 2018-2030 (USD Million)
Table 26 Germany alopecia market, by gender, 2018-2030 (USD Million)
Table 27 Germany alopecia market, by sales channel, 2018-2030 (USD Million)
Table 28 Germany alopecia market, by end user, 2018-2030 (USD Million)
Table 29 UK alopecia market, by disease type, 2018-2030 (USD Million)
Table 30 UK alopecia market, by treatment, 2018-2030 (USD Million)
Table 31 UK alopecia market, by gender, 2018-2030 (USD Million)
Table 32 UK alopecia market, by sales channel, 2018-2030 (USD Million)
Table 33 UK alopecia market, by end user, 2018-2030 (USD Million)
Table 34 France alopecia market, by disease type, 2018-2030 (USD Million)
Table 35 France alopecia market, by treatment, 2018-2030 (USD Million)
Table 36 France alopecia market, by gender, 2018-2030 (USD Million)
Table 37 France alopecia market, by sales channel, 2018-2030 (USD Million)
Table 38 France alopecia market, by end user, 2018-2030 (USD Million)
Table 39 Italy alopecia market, by disease type, 2018-2030 (USD Million)
Table 40 Italy alopecia market, by treatment, 2018-2030 (USD Million)
Table 41 Italy alopecia market, by gender, 2018-2030 (USD Million)
Table 42 Italy alopecia market, by sales channel, 2018-2030 (USD Million)
Table 43 Italy alopecia market, by end user, 2018-2030 (USD Million)
Table 44 Spain alopecia market, by disease type, 2018-2030 (USD Million)
Table 45 Spain alopecia market, by treatment, 2018-2030 (USD Million)
Table 46 Spain alopecia market, by gender, 2018-2030 (USD Million)
Table 47 Spain alopecia market, by sales channel, 2018-2030 (USD Million)
Table 48 Spain alopecia market, by end user, 2018-2030 (USD Million)
Table 49 Denmark alopecia market, by disease type, 2018-2030 (USD Million)
Table 50 Denmark alopecia market, by treatment, 2018-2030 (USD Million)
Table 51 Denmark alopecia market, by gender, 2018-2030 (USD Million)
Table 52 Denmark alopecia market, by sales channel, 2018-2030 (USD Million)
Table 53 Denmark alopecia market, by end user, 2018-2030 (USD Million)
Table 54 Sweden alopecia market, by disease type, 2018-2030 (USD Million)
Table 55 Sweden alopecia market, by treatment, 2018-2030 (USD Million)
Table 56 Sweden alopecia market, by gender, 2018-2030 (USD Million)
Table 57 Sweden alopecia market, by sales channel, 2018-2030 (USD Million)
Table 58 Sweden alopecia market, by end user, 2018-2030 (USD Million)
Table 59 Norway alopecia market, by disease type, 2018-2030 (USD Million)
Table 60 Norway alopecia market, by treatment, 2018-2030 (USD Million)
Table 61 Norway alopecia market, by gender, 2018-2030 (USD Million)
Table 62 Norway alopecia market, by sales channel, 2018-2030 (USD Million)
Table 63 Norway alopecia market, by end user, 2018-2030 (USD Million)
Table 64 Asia-Pacific alopecia market, by region, 2018-2030 (USD Million)
Table 65 Asia-Pacific alopecia market, by disease type, 2018-2030 (USD Million)
Table 66 Asia-Pacific alopecia market, by treatment, 2018-2030 (USD Million)
Table 67 Asia-Pacific alopecia market, by gender, 2018-2030 (USD Million)
Table 68 Asia-Pacific alopecia market, by sales channel, 2018-2030 (USD Million)
Table 69 Asia-Pacific alopecia market, by end user, 2018-2030 (USD Million)
Table 70 China alopecia market, by disease type, 2018-2030 (USD Million)
Table 71 China alopecia market, by treatment, 2018-2030 (USD Million)
Table 72 China alopecia market, by gender, 2018-2030 (USD Million)
Table 73 China alopecia market, by sales channel, 2018-2030 (USD Million)
Table 74 China alopecia market, by end user, 2018-2030 (USD Million)
Table 75 Japan alopecia market, by disease type, 2018-2030 (USD Million)
Table 76 Japan alopecia market, by treatment, 2018-2030 (USD Million)
Table 77 Japan alopecia market, by gender, 2018-2030 (USD Million)
Table 78 Japan alopecia market, by sales channel, 2018-2030 (USD Million)
Table 79 Japan alopecia market, by end user, 2018-2030 (USD Million)
Table 80 India alopecia market, by disease type, 2018-2030 (USD Million)
Table 81 India alopecia market, by treatment, 2018-2030 (USD Million)
Table 82 India alopecia market, by gender, 2018-2030 (USD Million)
Table 83 India alopecia market, by sales channel, 2018-2030 (USD Million)
Table 84 India alopecia market, by end user, 2018-2030 (USD Million)
Table 85 South Korea alopecia market, by disease type, 2018-2030 (USD Million)
Table 86 South Korea alopecia market, by treatment, 2018-2030 (USD Million)
Table 87 South Korea alopecia market, by gender, 2018-2030 (USD Million)
Table 88 South Korea alopecia market, by sales channel, 2018-2030 (USD Million)
Table 89 South Korea alopecia market, by end user, 2018-2030 (USD Million)
Table 90 Australia alopecia market, by disease type, 2018-2030 (USD Million)
Table 91 Australia alopecia market, by treatment, 2018-2030 (USD Million)
Table 92 Australia alopecia market, by gender, 2018-2030 (USD Million)
Table 93 Australia alopecia market, by sales channel, 2018-2030 (USD Million)
Table 94 Australia alopecia market, by end user, 2018-2030 (USD Million)
Table 95 Thailand alopecia market, by disease type, 2018-2030 (USD Million)
Table 96 Thailand alopecia market, by treatment, 2018-2030 (USD Million)
Table 97 Thailand alopecia market, by gender, 2018-2030 (USD Million)
Table 98 Thailand alopecia market, by sales channel, 2018-2030 (USD Million)
Table 99 Thailand alopecia market, by end user, 2018-2030 (USD Million)
Table 100 Latin America alopecia market, by disease type, 2018-2030 (USD Million)
Table 101 Latin America alopecia market, by treatment, 2018-2030 (USD Million)
Table 102 Latin America alopecia market, by gender, 2018-2030 (USD Million)
Table 103 Latin America alopecia market, by sales channel, 2018-2030 (USD Million)
Table 104 Latin America alopecia market, by end user, 2018-2030 (USD Million)
Table 105 Brazil alopecia market, by disease type, 2018-2030 (USD Million)
Table 106 Brazil alopecia market, by treatment, 2018-2030 (USD Million)
Table 107 Brazil alopecia market, by gender, 2018-2030 (USD Million)
Table 108 Brazil alopecia market, by sales channel, 2018-2030 (USD Million)
Table 109 Brazil alopecia market, by end user, 2018-2030 (USD Million)
Table 110 Mexico alopecia market, by disease type, 2018-2030 (USD Million)
Table 111 Mexico alopecia market, by treatment, 2018-2030 (USD Million)
Table 112 Mexico alopecia market, by gender, 2018-2030 (USD Million)
Table 113 Mexico alopecia market, by sales channel, 2018-2030 (USD Million)
Table 114 Mexico alopecia market, by end user, 2018-2030 (USD Million)
Table 115 Argentina alopecia market, by disease type, 2018-2030 (USD Million)
Table 116 Argentina alopecia market, by treatment, 2018-2030 (USD Million)
Table 117 Argentina alopecia market, by gender, 2018-2030 (USD Million)
Table 118 Argentina alopecia market, by sales channel, 2018-2030 (USD Million)
Table 119 Argentina alopecia market, by end user, 2018-2030 (USD Million)
Table 120 MEA alopecia market, by region, 2018-2030 (USD Million)
Table 121 MEA alopecia market, by disease type, 2018-2030 (USD Million)
Table 122 MEA alopecia market, by treatment, 2018-2030 (USD Million)
Table 123 MEA alopecia market, by gender, 2018-2030 (USD Million)
Table 124 MEA alopecia market, by sales channel, 2018-2030 (USD Million)
Table 125 MEA alopecia market, by end user, 2018-2030 (USD Million)
Table 126 South Africa alopecia market, by disease type, 2018-2030 (USD Million)
Table 127 South Africa alopecia market, by treatment, 2018-2030 (USD Million)
Table 128 South Africa alopecia market, by gender, 2018-2030 (USD Million)
Table 129 South Africa alopecia market, by sales channel, 2018-2030 (USD Million)
Table 130 South Africa alopecia market, by end user, 2018-2030 (USD Million)
Table 131 Saudi Arabia alopecia market, by disease type, 2018-2030 (USD Million)
Table 132 Saudi Arabia alopecia market, by treatment, 2018-2030 (USD Million)
Table 133 Saudi Arabia alopecia market, by gender, 2018-2030 (USD Million)
Table 134 Saudi Arabia alopecia market, by sales channel, 2018-2030 (USD Million)
Table 135 Saudi Arabia alopecia market, by end user, 2018-2030 (USD Million)
Table 136 UAE alopecia market, by disease type, 2018-2030 (USD Million)
Table 137 UAE alopecia market, by treatment, 2018-2030 (USD Million)
Table 138 UAE alopecia market, by gender, 2018-2030 (USD Million)
Table 139 UAE alopecia market, by sales channel, 2018-2030 (USD Million)
Table 140 UAE alopecia market, by end user, 2018-2030 (USD Million)
Table 141 Kuwait alopecia market, by disease type, 2018-2030 (USD Million)
Table 142 Kuwait alopecia market, by treatment, 2018-2030 (USD Million)
Table 143 Kuwait alopecia market, by gender, 2018-2030 (USD Million)
Table 144 Kuwait alopecia market, by sales channel, 2018-2030 (USD Million)
Table 145 Kuwait alopecia market, by end user, 2018-2030 (USD Million)
Table 2 North America alopecia market, by region, 2018-2030 (USD Million)
Table 3 North America alopecia market, by disease type, 2018-2030 (USD Million)
Table 4 North America alopecia market, by treatment, 2018-2030 (USD Million)
Table 5 North America alopecia market, by gender, 2018-2030 (USD Million)
Table 6 North America alopecia market, by sales channel, 2018-2030 (USD Million)
Table 7 North America alopecia market, by end user, 2018-2030 (USD Million)
Table 8 U.S. alopecia market, by disease type, 2018-2030 (USD Million)
Table 9 U.S. alopecia market, by treatment, 2018-2030 (USD Million)
Table 10 U.S. alopecia market, by gender, 2018-2030 (USD Million)
Table 11 U.S. alopecia market, by sales channel, 2018-2030 (USD Million)
Table 12 U.S. alopecia market, by end user, 2018-2030 (USD Million)
Table 13 Canada alopecia market, by disease type, 2018-2030 (USD Million)
Table 14 Canada alopecia market, by treatment, 2018-2030 (USD Million)
Table 15 Canada alopecia market, by gender, 2018-2030 (USD Million)
Table 16 Canada alopecia market, by sales channel, 2018-2030 (USD Million)
Table 17 Canada alopecia market, by end user, 2018-2030 (USD Million)
Table 18 Europe alopecia market, by region, 2018-2030 (USD Million)
Table 19 Europe alopecia market, by disease type, 2018-2030 (USD Million)
Table 20 Europe alopecia market, by treatment, 2018-2030 (USD Million)
Table 21 Europe alopecia market, by gender, 2018-2030 (USD Million)
Table 22 Europe alopecia market, by sales channel, 2018-2030 (USD Million)
Table 23 Europe alopecia market, by end user, 2018-2030 (USD Million)
Table 24 Germany alopecia market, by disease type, 2018-2030 (USD Million)
Table 25 Germany alopecia market, by treatment, 2018-2030 (USD Million)
Table 26 Germany alopecia market, by gender, 2018-2030 (USD Million)
Table 27 Germany alopecia market, by sales channel, 2018-2030 (USD Million)
Table 28 Germany alopecia market, by end user, 2018-2030 (USD Million)
Table 29 UK alopecia market, by disease type, 2018-2030 (USD Million)
Table 30 UK alopecia market, by treatment, 2018-2030 (USD Million)
Table 31 UK alopecia market, by gender, 2018-2030 (USD Million)
Table 32 UK alopecia market, by sales channel, 2018-2030 (USD Million)
Table 33 UK alopecia market, by end user, 2018-2030 (USD Million)
Table 34 France alopecia market, by disease type, 2018-2030 (USD Million)
Table 35 France alopecia market, by treatment, 2018-2030 (USD Million)
Table 36 France alopecia market, by gender, 2018-2030 (USD Million)
Table 37 France alopecia market, by sales channel, 2018-2030 (USD Million)
Table 38 France alopecia market, by end user, 2018-2030 (USD Million)
Table 39 Italy alopecia market, by disease type, 2018-2030 (USD Million)
Table 40 Italy alopecia market, by treatment, 2018-2030 (USD Million)
Table 41 Italy alopecia market, by gender, 2018-2030 (USD Million)
Table 42 Italy alopecia market, by sales channel, 2018-2030 (USD Million)
Table 43 Italy alopecia market, by end user, 2018-2030 (USD Million)
Table 44 Spain alopecia market, by disease type, 2018-2030 (USD Million)
Table 45 Spain alopecia market, by treatment, 2018-2030 (USD Million)
Table 46 Spain alopecia market, by gender, 2018-2030 (USD Million)
Table 47 Spain alopecia market, by sales channel, 2018-2030 (USD Million)
Table 48 Spain alopecia market, by end user, 2018-2030 (USD Million)
Table 49 Denmark alopecia market, by disease type, 2018-2030 (USD Million)
Table 50 Denmark alopecia market, by treatment, 2018-2030 (USD Million)
Table 51 Denmark alopecia market, by gender, 2018-2030 (USD Million)
Table 52 Denmark alopecia market, by sales channel, 2018-2030 (USD Million)
Table 53 Denmark alopecia market, by end user, 2018-2030 (USD Million)
Table 54 Sweden alopecia market, by disease type, 2018-2030 (USD Million)
Table 55 Sweden alopecia market, by treatment, 2018-2030 (USD Million)
Table 56 Sweden alopecia market, by gender, 2018-2030 (USD Million)
Table 57 Sweden alopecia market, by sales channel, 2018-2030 (USD Million)
Table 58 Sweden alopecia market, by end user, 2018-2030 (USD Million)
Table 59 Norway alopecia market, by disease type, 2018-2030 (USD Million)
Table 60 Norway alopecia market, by treatment, 2018-2030 (USD Million)
Table 61 Norway alopecia market, by gender, 2018-2030 (USD Million)
Table 62 Norway alopecia market, by sales channel, 2018-2030 (USD Million)
Table 63 Norway alopecia market, by end user, 2018-2030 (USD Million)
Table 64 Asia-Pacific alopecia market, by region, 2018-2030 (USD Million)
Table 65 Asia-Pacific alopecia market, by disease type, 2018-2030 (USD Million)
Table 66 Asia-Pacific alopecia market, by treatment, 2018-2030 (USD Million)
Table 67 Asia-Pacific alopecia market, by gender, 2018-2030 (USD Million)
Table 68 Asia-Pacific alopecia market, by sales channel, 2018-2030 (USD Million)
Table 69 Asia-Pacific alopecia market, by end user, 2018-2030 (USD Million)
Table 70 China alopecia market, by disease type, 2018-2030 (USD Million)
Table 71 China alopecia market, by treatment, 2018-2030 (USD Million)
Table 72 China alopecia market, by gender, 2018-2030 (USD Million)
Table 73 China alopecia market, by sales channel, 2018-2030 (USD Million)
Table 74 China alopecia market, by end user, 2018-2030 (USD Million)
Table 75 Japan alopecia market, by disease type, 2018-2030 (USD Million)
Table 76 Japan alopecia market, by treatment, 2018-2030 (USD Million)
Table 77 Japan alopecia market, by gender, 2018-2030 (USD Million)
Table 78 Japan alopecia market, by sales channel, 2018-2030 (USD Million)
Table 79 Japan alopecia market, by end user, 2018-2030 (USD Million)
Table 80 India alopecia market, by disease type, 2018-2030 (USD Million)
Table 81 India alopecia market, by treatment, 2018-2030 (USD Million)
Table 82 India alopecia market, by gender, 2018-2030 (USD Million)
Table 83 India alopecia market, by sales channel, 2018-2030 (USD Million)
Table 84 India alopecia market, by end user, 2018-2030 (USD Million)
Table 85 South Korea alopecia market, by disease type, 2018-2030 (USD Million)
Table 86 South Korea alopecia market, by treatment, 2018-2030 (USD Million)
Table 87 South Korea alopecia market, by gender, 2018-2030 (USD Million)
Table 88 South Korea alopecia market, by sales channel, 2018-2030 (USD Million)
Table 89 South Korea alopecia market, by end user, 2018-2030 (USD Million)
Table 90 Australia alopecia market, by disease type, 2018-2030 (USD Million)
Table 91 Australia alopecia market, by treatment, 2018-2030 (USD Million)
Table 92 Australia alopecia market, by gender, 2018-2030 (USD Million)
Table 93 Australia alopecia market, by sales channel, 2018-2030 (USD Million)
Table 94 Australia alopecia market, by end user, 2018-2030 (USD Million)
Table 95 Thailand alopecia market, by disease type, 2018-2030 (USD Million)
Table 96 Thailand alopecia market, by treatment, 2018-2030 (USD Million)
Table 97 Thailand alopecia market, by gender, 2018-2030 (USD Million)
Table 98 Thailand alopecia market, by sales channel, 2018-2030 (USD Million)
Table 99 Thailand alopecia market, by end user, 2018-2030 (USD Million)
Table 100 Latin America alopecia market, by disease type, 2018-2030 (USD Million)
Table 101 Latin America alopecia market, by treatment, 2018-2030 (USD Million)
Table 102 Latin America alopecia market, by gender, 2018-2030 (USD Million)
Table 103 Latin America alopecia market, by sales channel, 2018-2030 (USD Million)
Table 104 Latin America alopecia market, by end user, 2018-2030 (USD Million)
Table 105 Brazil alopecia market, by disease type, 2018-2030 (USD Million)
Table 106 Brazil alopecia market, by treatment, 2018-2030 (USD Million)
Table 107 Brazil alopecia market, by gender, 2018-2030 (USD Million)
Table 108 Brazil alopecia market, by sales channel, 2018-2030 (USD Million)
Table 109 Brazil alopecia market, by end user, 2018-2030 (USD Million)
Table 110 Mexico alopecia market, by disease type, 2018-2030 (USD Million)
Table 111 Mexico alopecia market, by treatment, 2018-2030 (USD Million)
Table 112 Mexico alopecia market, by gender, 2018-2030 (USD Million)
Table 113 Mexico alopecia market, by sales channel, 2018-2030 (USD Million)
Table 114 Mexico alopecia market, by end user, 2018-2030 (USD Million)
Table 115 Argentina alopecia market, by disease type, 2018-2030 (USD Million)
Table 116 Argentina alopecia market, by treatment, 2018-2030 (USD Million)
Table 117 Argentina alopecia market, by gender, 2018-2030 (USD Million)
Table 118 Argentina alopecia market, by sales channel, 2018-2030 (USD Million)
Table 119 Argentina alopecia market, by end user, 2018-2030 (USD Million)
Table 120 MEA alopecia market, by region, 2018-2030 (USD Million)
Table 121 MEA alopecia market, by disease type, 2018-2030 (USD Million)
Table 122 MEA alopecia market, by treatment, 2018-2030 (USD Million)
Table 123 MEA alopecia market, by gender, 2018-2030 (USD Million)
Table 124 MEA alopecia market, by sales channel, 2018-2030 (USD Million)
Table 125 MEA alopecia market, by end user, 2018-2030 (USD Million)
Table 126 South Africa alopecia market, by disease type, 2018-2030 (USD Million)
Table 127 South Africa alopecia market, by treatment, 2018-2030 (USD Million)
Table 128 South Africa alopecia market, by gender, 2018-2030 (USD Million)
Table 129 South Africa alopecia market, by sales channel, 2018-2030 (USD Million)
Table 130 South Africa alopecia market, by end user, 2018-2030 (USD Million)
Table 131 Saudi Arabia alopecia market, by disease type, 2018-2030 (USD Million)
Table 132 Saudi Arabia alopecia market, by treatment, 2018-2030 (USD Million)
Table 133 Saudi Arabia alopecia market, by gender, 2018-2030 (USD Million)
Table 134 Saudi Arabia alopecia market, by sales channel, 2018-2030 (USD Million)
Table 135 Saudi Arabia alopecia market, by end user, 2018-2030 (USD Million)
Table 136 UAE alopecia market, by disease type, 2018-2030 (USD Million)
Table 137 UAE alopecia market, by treatment, 2018-2030 (USD Million)
Table 138 UAE alopecia market, by gender, 2018-2030 (USD Million)
Table 139 UAE alopecia market, by sales channel, 2018-2030 (USD Million)
Table 140 UAE alopecia market, by end user, 2018-2030 (USD Million)
Table 141 Kuwait alopecia market, by disease type, 2018-2030 (USD Million)
Table 142 Kuwait alopecia market, by treatment, 2018-2030 (USD Million)
Table 143 Kuwait alopecia market, by gender, 2018-2030 (USD Million)
Table 144 Kuwait alopecia market, by sales channel, 2018-2030 (USD Million)
Table 145 Kuwait alopecia market, by end user, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alopecia market: market outlook
Fig. 14 Alopecia competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alopecia market driver impact
Fig. 20 Alopecia market restraint impact
Fig. 21 Alopecia market strategic initiatives analysis
Fig. 22 Alopecia market: Disease type movement analysis
Fig. 23 Alopecia market: Disease type outlook and key takeaways
Fig. 24 Alopecia areata market estimates and forecast, 2018-2030
Fig. 25 Male alopecia areata market estimates and forecast, 2018-2030
Fig. 26 Female alopecia areata market estimates and forecast, 2018-2030
Fig. 27 Cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 30 Traction alopecia market estimates and forecast, 2018-2030
Fig. 31 Male traction market estimates and forecast, 2018-2030
Fig. 32 Female traction market estimates and forecast, 2018-2030
Fig. 33 Alopecia totalis market estimates and forecast, 2018-2030
Fig. 34 Male alopecia totalis market estimates and forecast, 2018-2030
Fig. 35 Female alopecia totalis market estimates and forecast, 2018-2030
Fig. 36 Alopecia universalis market estimates and forecast, 2018-2030
Fig. 37 Male alopecia universalis market estimates and forecast, 2018-2030
Fig. 38 Female alopecia universalis market estimates and forecast, 2018-2030
Fig. 39 Androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 42 Other alopecia market estimates and forecast, 2018-2030
Fig. 43 Male other alopecia market estimates and forecast, 2018-2030
Fig. 44 Female other alopecia market estimates and forecast, 2018-2030
Fig. 45 Alopecia Market: Treatment movement Analysis
Fig. 46 Alopecia market: Treatment outlook and key takeaways
Fig. 47 Pharmaceuticals market estimates and forecasts, 2018-2030
Fig. 48 Topical market estimates and forecasts,2018-2030
Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts,2018-2030
Fig. 50 Topical OTC minoxidil market estimates and forecasts,2018-2030
Fig. 51 Topical OTC others market estimates and forecasts,2018-2030
Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts,2018-2030
Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts,2018-2030
Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts,2018-2030
Fig. 55 Topical prescription finasteride market estimates and forecasts,2018-2030
Fig. 56 Topical prescription minoxidil market estimates and forecasts,2018-2030
Fig. 57 Oral pharmaceuticals market estimates and forecasts,2018-2030
Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts,2018-2030
Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts,2018-2030
Fig. 60 Oral prescription minoxidil market estimates and forecasts,2018-2030
Fig. 61 Oral prescription finasteride market estimates and forecasts,2018-2030
Fig. 62 Oral prescription corticosteroids market estimates and forecasts,2018-2030
Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts,2018-2030
Fig. 64 PRP market estimates and forecasts,2018-2030
Fig. 65 Devices market estimates and forecasts,2018-2030
Fig. 66 Laser cap market estimates and forecasts,2018-2030
Fig. 67 Laser comb market estimates and forecasts,2018-2030
Fig. 68 Laser helmet market estimates and forecasts,2018-2030
Fig. 69 Alopecia market: Gender movement analysis
Fig. 70 Alopecia market: Gender outlook and key takeaways
Fig. 71 Male market estimates and forecasts, 2018-2030
Fig. 72 Female market estimates and forecasts,2018-2030
Fig. 73 Alopecia market: Sales channel movement analysis
Fig. 74 Alopecia market: Sales channel outlook and key takeaways
Fig. 75 Prescriptions market estimates and forecasts, 2018-2030
Fig. 76 OTC market estimates and forecasts,2018-2030
Fig. 77 Alopecia market: End use movement analysis
Fig. 78 Alopecia market: End use outlook and key takeaways
Fig. 79 Homecare settings market estimates and forecasts, 2018-2030
Fig. 80 Dermatology clinics market estimates and forecasts,2018-2030
Fig. 81 Global alopecia market: Regional movement analysis
Fig. 82 Global alopecia market: Regional outlook and key takeaways
Fig. 83 Global alopecia market share and leading players
Fig. 84 North America market share and leading players
Fig. 85 Europe market share and leading players
Fig. 86 Asia-Pacific market share and leading players
Fig. 87 Latin America market share and leading players
Fig. 88 Middle East & Africa market share and leading players
Fig. 89 North America: SWOT
Fig. 90 Europe SWOT
Fig. 91 Asia-Pacific SWOT
Fig. 92 Latin America SWOT
Fig. 93 MEA SWOT
Fig. 94 North America, by country
Fig. 95 North America
Fig. 96 North America market estimates and forecasts, 2018-2030
Fig. 97 U.S.
Fig. 98 U.S. market estimates and forecasts, 2018-2030
Fig. 99 Canada
Fig. 100 Canada market estimates and forecasts, 2018-2030
Fig. 101 Europe
Fig. 102 Europe market estimates and forecasts, 2018-2030
Fig. 103 UK
Fig. 104 UK market estimates and forecasts, 2018-2030
Fig. 105 Germany
Fig. 106 Germany market estimates and forecasts, 2018-2030
Fig. 107 France
Fig. 108 France market estimates and forecasts, 2018-2030
Fig. 109 Italy
Fig. 110 Italy market estimates and forecasts, 2018-2030
Fig. 111 Spain
Fig. 112 Spain market estimates and forecasts, 2018-2030
Fig. 113 Denmark
Fig. 114 Denmark market estimates and forecasts, 2018-2030
Fig. 115 Sweden
Fig. 116 Sweden market estimates and forecasts, 2018-2030
Fig. 117 Norway
Fig. 118 Norway market estimates and forecasts, 2018-2030
Fig. 119 Asia-Pacific
Fig. 120 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 121 China
Fig. 122 China market estimates and forecasts, 2018-2030
Fig. 123 Japan
Fig. 124 Japan market estimates and forecasts, 2018-2030
Fig. 125 India
Fig. 126 India market estimates and forecasts, 2018-2030
Fig. 127 Thailand
Fig. 128 Thailand market estimates and forecasts, 2018-2030
Fig. 129 South Korea
Fig. 130 South Korea market estimates and forecasts, 2018-2030
Fig. 131 Australia
Fig. 132 Australia market estimates and forecasts, 2018-2030
Fig. 133 Latin America
Fig. 134 Latin America market estimates and forecasts, 2018-2030
Fig. 135 Brazil
Fig. 136 Brazil market estimates and forecasts, 2018-2030
Fig. 137 Mexico
Fig. 138 Mexico market estimates and forecasts, 2018-2030
Fig. 139 Argentina
Fig. 140 Argentina market estimates and forecasts, 2018-2030
Fig. 141 Middle East and Africa
Fig. 142 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 143 South Africa
Fig. 144 South Africa market estimates and forecasts, 2018-2030
Fig. 145 Saudi Arabia
Fig. 146 Saudi Arabia market estimates and forecasts, 2018-2030
Fig. 147 UAE
Fig. 148 UAE market estimates and forecasts, 2018-2030
Fig. 149 Kuwait
Fig. 150 Kuwait market estimates and forecasts, 2018-2030
Fig. 151 Market share of key market players- Alopecia market
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Alopecia market: market outlook
Fig. 14 Alopecia competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Alopecia market driver impact
Fig. 20 Alopecia market restraint impact
Fig. 21 Alopecia market strategic initiatives analysis
Fig. 22 Alopecia market: Disease type movement analysis
Fig. 23 Alopecia market: Disease type outlook and key takeaways
Fig. 24 Alopecia areata market estimates and forecast, 2018-2030
Fig. 25 Male alopecia areata market estimates and forecast, 2018-2030
Fig. 26 Female alopecia areata market estimates and forecast, 2018-2030
Fig. 27 Cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 28 Male cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 29 Female cicatricial alopecia market estimates and forecast, 2018-2030
Fig. 30 Traction alopecia market estimates and forecast, 2018-2030
Fig. 31 Male traction market estimates and forecast, 2018-2030
Fig. 32 Female traction market estimates and forecast, 2018-2030
Fig. 33 Alopecia totalis market estimates and forecast, 2018-2030
Fig. 34 Male alopecia totalis market estimates and forecast, 2018-2030
Fig. 35 Female alopecia totalis market estimates and forecast, 2018-2030
Fig. 36 Alopecia universalis market estimates and forecast, 2018-2030
Fig. 37 Male alopecia universalis market estimates and forecast, 2018-2030
Fig. 38 Female alopecia universalis market estimates and forecast, 2018-2030
Fig. 39 Androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 40 Male androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 41 Female androgenetic alopecia market estimates and forecast, 2018-2030
Fig. 42 Other alopecia market estimates and forecast, 2018-2030
Fig. 43 Male other alopecia market estimates and forecast, 2018-2030
Fig. 44 Female other alopecia market estimates and forecast, 2018-2030
Fig. 45 Alopecia Market: Treatment movement Analysis
Fig. 46 Alopecia market: Treatment outlook and key takeaways
Fig. 47 Pharmaceuticals market estimates and forecasts, 2018-2030
Fig. 48 Topical market estimates and forecasts,2018-2030
Fig. 49 Topical OTC pharmaceuticals market estimates and forecasts,2018-2030
Fig. 50 Topical OTC minoxidil market estimates and forecasts,2018-2030
Fig. 51 Topical OTC others market estimates and forecasts,2018-2030
Fig. 52 Topical prescription pharmaceuticals market estimates and forecasts,2018-2030
Fig. 53 Topical prescription betamethasone dipropionate market estimates and forecasts,2018-2030
Fig. 54 Topical prescription fluocinolone acetonide market estimates and forecasts,2018-2030
Fig. 55 Topical prescription finasteride market estimates and forecasts,2018-2030
Fig. 56 Topical prescription minoxidil market estimates and forecasts,2018-2030
Fig. 57 Oral pharmaceuticals market estimates and forecasts,2018-2030
Fig. 58 Oral OTC pharmaceuticals market estimates and forecasts,2018-2030
Fig. 59 Oral prescription pharmaceuticals market estimates and forecasts,2018-2030
Fig. 60 Oral prescription minoxidil market estimates and forecasts,2018-2030
Fig. 61 Oral prescription finasteride market estimates and forecasts,2018-2030
Fig. 62 Oral prescription corticosteroids market estimates and forecasts,2018-2030
Fig. 63 Oral prescription others (JAK inhibitors and others) market estimates and forecasts,2018-2030
Fig. 64 PRP market estimates and forecasts,2018-2030
Fig. 65 Devices market estimates and forecasts,2018-2030
Fig. 66 Laser cap market estimates and forecasts,2018-2030
Fig. 67 Laser comb market estimates and forecasts,2018-2030
Fig. 68 Laser helmet market estimates and forecasts,2018-2030
Fig. 69 Alopecia market: Gender movement analysis
Fig. 70 Alopecia market: Gender outlook and key takeaways
Fig. 71 Male market estimates and forecasts, 2018-2030
Fig. 72 Female market estimates and forecasts,2018-2030
Fig. 73 Alopecia market: Sales channel movement analysis
Fig. 74 Alopecia market: Sales channel outlook and key takeaways
Fig. 75 Prescriptions market estimates and forecasts, 2018-2030
Fig. 76 OTC market estimates and forecasts,2018-2030
Fig. 77 Alopecia market: End use movement analysis
Fig. 78 Alopecia market: End use outlook and key takeaways
Fig. 79 Homecare settings market estimates and forecasts, 2018-2030
Fig. 80 Dermatology clinics market estimates and forecasts,2018-2030
Fig. 81 Global alopecia market: Regional movement analysis
Fig. 82 Global alopecia market: Regional outlook and key takeaways
Fig. 83 Global alopecia market share and leading players
Fig. 84 North America market share and leading players
Fig. 85 Europe market share and leading players
Fig. 86 Asia-Pacific market share and leading players
Fig. 87 Latin America market share and leading players
Fig. 88 Middle East & Africa market share and leading players
Fig. 89 North America: SWOT
Fig. 90 Europe SWOT
Fig. 91 Asia-Pacific SWOT
Fig. 92 Latin America SWOT
Fig. 93 MEA SWOT
Fig. 94 North America, by country
Fig. 95 North America
Fig. 96 North America market estimates and forecasts, 2018-2030
Fig. 97 U.S.
Fig. 98 U.S. market estimates and forecasts, 2018-2030
Fig. 99 Canada
Fig. 100 Canada market estimates and forecasts, 2018-2030
Fig. 101 Europe
Fig. 102 Europe market estimates and forecasts, 2018-2030
Fig. 103 UK
Fig. 104 UK market estimates and forecasts, 2018-2030
Fig. 105 Germany
Fig. 106 Germany market estimates and forecasts, 2018-2030
Fig. 107 France
Fig. 108 France market estimates and forecasts, 2018-2030
Fig. 109 Italy
Fig. 110 Italy market estimates and forecasts, 2018-2030
Fig. 111 Spain
Fig. 112 Spain market estimates and forecasts, 2018-2030
Fig. 113 Denmark
Fig. 114 Denmark market estimates and forecasts, 2018-2030
Fig. 115 Sweden
Fig. 116 Sweden market estimates and forecasts, 2018-2030
Fig. 117 Norway
Fig. 118 Norway market estimates and forecasts, 2018-2030
Fig. 119 Asia-Pacific
Fig. 120 Asia-Pacific market estimates and forecasts, 2018-2030
Fig. 121 China
Fig. 122 China market estimates and forecasts, 2018-2030
Fig. 123 Japan
Fig. 124 Japan market estimates and forecasts, 2018-2030
Fig. 125 India
Fig. 126 India market estimates and forecasts, 2018-2030
Fig. 127 Thailand
Fig. 128 Thailand market estimates and forecasts, 2018-2030
Fig. 129 South Korea
Fig. 130 South Korea market estimates and forecasts, 2018-2030
Fig. 131 Australia
Fig. 132 Australia market estimates and forecasts, 2018-2030
Fig. 133 Latin America
Fig. 134 Latin America market estimates and forecasts, 2018-2030
Fig. 135 Brazil
Fig. 136 Brazil market estimates and forecasts, 2018-2030
Fig. 137 Mexico
Fig. 138 Mexico market estimates and forecasts, 2018-2030
Fig. 139 Argentina
Fig. 140 Argentina market estimates and forecasts, 2018-2030
Fig. 141 Middle East and Africa
Fig. 142 Middle East and Africa market estimates and forecasts, 2018-2030
Fig. 143 South Africa
Fig. 144 South Africa market estimates and forecasts, 2018-2030
Fig. 145 Saudi Arabia
Fig. 146 Saudi Arabia market estimates and forecasts, 2018-2030
Fig. 147 UAE
Fig. 148 UAE market estimates and forecasts, 2018-2030
Fig. 149 Kuwait
Fig. 150 Kuwait market estimates and forecasts, 2018-2030
Fig. 151 Market share of key market players- Alopecia market
Companies Mentioned
- Janssen Global Services Inc.
- Cipla Limited
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Sun Pharmaceuticals Industries Ltd
- Dr. Reddy’s Laboratories Ltd
- Aurobindo Pharma
- Viatris Inc.
- Pfizer, Inc.
- Lilly
- Lexington Intl., LLC (Devices)
- Freedom Laser Therapy (iRestore ID-520 helmet)
- Curallux, LLC.
- Apira Science Inc. (iGROW Laser)
- Revian Inc.
- Theradome
- Lutronic
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 8.77 Billion |
| Forecasted Market Value ( USD | $ 16.02 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
